Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2021 | Real-world use of OncotypeDx testing in the management of breast cancer in the North East

Abigail Gault and Wendy Taylor • 9 Dec 2021
SABCS 2021
Breast Cancer

Wendy Taylor, MBBS, and Abigail Gault, MBBS, MRCP, PGCert, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK, provide an overview of the real-world use of OncotypeDx testing in the management of breast cancer in North East England. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

More from Abigail Gault

3:44
Importance of real-world data in oncology
Abigail Gault et al. • 9 Dec 2021
1:18
Genomic testing in identifying patients with DCIS likely to respond to radiotherapy
Abigail Gault et al. • 9 Dec 2021

More from Wendy Taylor

3:44
Importance of real-world data in oncology
Abigail Gault et al. • 9 Dec 2021
1:18
Genomic testing in identifying patients with DCIS likely to respond to radiotherapy
Abigail Gault et al. • 9 Dec 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals